vs
DiamondRock Hospitality Co（DRH）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
DiamondRock Hospitality Co的季度营收约是Orthofix Medical Inc.的1.2倍（$258.2M vs $219.9M），DiamondRock Hospitality Co净利率更高（5.6% vs -1.0%，领先6.6%），Orthofix Medical Inc.同比增速更快（2.0% vs 1.3%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -8.6%）
DiamondRock Hospitality Co是一家总部位于美国的房地产投资信托企业，持有并运营一系列高端酒店及度假物业，项目主要分布在全美核心城市的商务及旅游集聚区，面向休闲旅客和商务客群提供高品质住宿服务。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DRH vs OFIX — 直观对比
营收规模更大
DRH
是对方的1.2倍
$219.9M
营收增速更快
OFIX
高出0.7%
1.3%
净利率更高
DRH
高出6.6%
-1.0%
两年增速更快
OFIX
近两年复合增速
-8.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $258.2M | $219.9M |
| 净利润 | $14.5M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 11.1% | 0.2% |
| 净利率 | 5.6% | -1.0% |
| 营收同比 | 1.3% | 2.0% |
| 净利润同比 | 22.0% | 92.4% |
| 每股收益（稀释后） | $0.07 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DRHOFIX
| Q1 26 | $258.2M | — | ||
| Q4 25 | $274.5M | $219.9M | ||
| Q3 25 | $285.4M | $205.6M | ||
| Q2 25 | $305.7M | $203.1M | ||
| Q1 25 | $254.9M | $193.6M | ||
| Q4 24 | $279.1M | $215.7M | ||
| Q3 24 | $285.1M | $196.6M | ||
| Q2 24 | $309.3M | $198.6M |
净利润DRHOFIX
| Q1 26 | $14.5M | — | ||
| Q4 25 | $26.2M | $-2.2M | ||
| Q3 25 | $22.5M | $-22.8M | ||
| Q2 25 | $40.8M | $-14.1M | ||
| Q1 25 | $11.9M | $-53.1M | ||
| Q4 24 | $-11.2M | $-29.1M | ||
| Q3 24 | $26.4M | $-27.4M | ||
| Q2 24 | $24.5M | $-33.4M |
毛利率DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率DRHOFIX
| Q1 26 | 11.1% | — | ||
| Q4 25 | 8.9% | 0.2% | ||
| Q3 25 | 8.1% | -8.3% | ||
| Q2 25 | 13.7% | -7.9% | ||
| Q1 25 | 4.3% | -25.2% | ||
| Q4 24 | -3.7% | -5.3% | ||
| Q3 24 | 9.5% | -9.6% | ||
| Q2 24 | 8.4% | -12.5% |
净利率DRHOFIX
| Q1 26 | 5.6% | — | ||
| Q4 25 | 9.5% | -1.0% | ||
| Q3 25 | 7.9% | -11.1% | ||
| Q2 25 | 13.4% | -6.9% | ||
| Q1 25 | 4.7% | -27.4% | ||
| Q4 24 | -4.0% | -13.5% | ||
| Q3 24 | 9.3% | -13.9% | ||
| Q2 24 | 7.9% | -16.8% |
每股收益（稀释后）DRHOFIX
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.12 | $-0.05 | ||
| Q3 25 | $0.10 | $-0.57 | ||
| Q2 25 | $0.18 | $-0.36 | ||
| Q1 25 | $0.04 | $-1.35 | ||
| Q4 24 | $-0.06 | $-0.76 | ||
| Q3 24 | $0.11 | $-0.71 | ||
| Q2 24 | $0.10 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $450.0M |
| 总资产 | $3.0B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DRHOFIX
| Q1 26 | $39.3M | — | ||
| Q4 25 | $68.1M | $82.0M | ||
| Q3 25 | $145.3M | $62.9M | ||
| Q2 25 | $52.4M | $65.6M | ||
| Q1 25 | $100.6M | $58.0M | ||
| Q4 24 | $81.4M | $83.2M | ||
| Q3 24 | $75.3M | $30.1M | ||
| Q2 24 | $125.2M | $26.4M |
总债务DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $157.2M | ||
| Q2 25 | $1.0B | $157.0M | ||
| Q1 25 | $1.1B | $156.9M | ||
| Q4 24 | $1.1B | $157.0M | ||
| Q3 24 | $1.1B | $118.5M | ||
| Q2 24 | $1.2B | $118.0M |
股东权益DRHOFIX
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $450.0M | ||
| Q3 25 | $1.6B | $442.5M | ||
| Q2 25 | $1.6B | $458.3M | ||
| Q1 25 | $1.6B | $458.3M | ||
| Q4 24 | $1.6B | $503.1M | ||
| Q3 24 | $1.6B | $525.9M | ||
| Q2 24 | $1.6B | $546.0M |
总资产DRHOFIX
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $850.6M | ||
| Q3 25 | $3.1B | $832.6M | ||
| Q2 25 | $3.1B | $837.2M | ||
| Q1 25 | $3.1B | $823.1M | ||
| Q4 24 | $3.2B | $893.3M | ||
| Q3 24 | $3.2B | $867.9M | ||
| Q2 24 | $3.2B | $882.0M |
负债/权益比DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.70× | 0.36× | ||
| Q2 25 | 0.65× | 0.34× | ||
| Q1 25 | 0.70× | 0.34× | ||
| Q4 24 | 0.69× | 0.31× | ||
| Q3 24 | 0.67× | 0.23× | ||
| Q2 24 | 0.71× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $67.9M | $27.7M | ||
| Q3 25 | $74.6M | $12.4M | ||
| Q2 25 | $73.6M | $11.6M | ||
| Q1 25 | $27.6M | $-18.4M | ||
| Q4 24 | $75.8M | $23.7M | ||
| Q3 24 | $61.7M | $11.7M | ||
| Q2 24 | $55.7M | $9.0M |
自由现金流DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $16.8M | ||
| Q3 25 | $54.9M | $2.5M | ||
| Q2 25 | $57.9M | $4.5M | ||
| Q1 25 | $2.0M | $-25.1M | ||
| Q4 24 | $52.6M | $15.2M | ||
| Q3 24 | $39.0M | $6.3M | ||
| Q2 24 | $38.8M | $-360.0K |
自由现金流率DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | 7.6% | ||
| Q3 25 | 19.2% | 1.2% | ||
| Q2 25 | 18.9% | 2.2% | ||
| Q1 25 | 0.8% | -13.0% | ||
| Q4 24 | 18.9% | 7.0% | ||
| Q3 24 | 13.7% | 3.2% | ||
| Q2 24 | 12.5% | -0.2% |
资本支出强度DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | 4.9% | ||
| Q3 25 | 6.9% | 4.8% | ||
| Q2 25 | 5.1% | 3.5% | ||
| Q1 25 | 10.0% | 3.5% | ||
| Q4 24 | 8.3% | 4.0% | ||
| Q3 24 | 7.9% | 2.7% | ||
| Q2 24 | 5.5% | 4.7% |
现金转化率DRHOFIX
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 2.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 2.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
